RELMADA THERAPEUT.DL-,001 |
USA |
Gesundheit |
US75955J4022 / A2PSZF |
4E2 (Frankfurt) / RLMD (NASDAQ) |
FRA:4E2, ETR:4E2, 4E2:GR, NASDAQ:RLMD |
- |
https://www.relmada.com/ |
Relmada Therapeutics Inc. is a clinical-stage biot..
>Volltext.. |
31.81 Mio. EUR |
14.32 Mio. EUR |
- |
-60.35 Mio. EUR |
-58.03 Mio. EUR |
-1.89 EUR |
- |
1.16 Mio. EUR |
-42.72 Mio. EUR |
4.02 |
- |
28.94% |
- |
- |
- |
RELMADA |
01.09.25 |
|